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The cytochrome P450 enzyme functions as the rate-limiting enzyme in changing androgens to estrogens. Inhi-
bition of aromatase is one of the significant objectives of treatment of hormone-dependent diseases such as breast
cancer, especially in post-menopausal women. Natural compounds like chrysin, as a flavor that has a high con-
centration in honey and propolis, are rich sources of them can be useful in inhibiting aromatase for chemopre-
vention following treatment or in women at risk of acquiring breast cancer. This study intended to summarize the
existing evidence on the effect of chrysin on aromatase activity. We systematically searched Science Direct,
PubMed and Google Scholar and hand searched the reference lists of identified relevant articles, up to 5 February,
2019. Articles with English abstracts that reported the effect of chrysin on aromatase inhibition and without
publication date restriction were investigated. Twenty relevant articles were chosen from a total of 1721 articles.
Only one study was performed on humans and two studies were assayed on rats, while other studies were
evaluated in vitro. All the studies except one showed that chrysin had the potency of aromatase inhibition;
however, only one study performed on endometrial stromal cells showed that chrysin and naringenin did not
indicate aromatase inhibitory properties. Various assay methods and experimental conditions were the important
aspects leading to different results between the studies. Chrysin has potency in inhibition of the aromatase
enzyme and thus can be useful in preventing and treating the hormone-dependent breast cancer and as an
adjuvant therapy for estrogen-dependent diseases.1. Introduction
Estrogens as steroid hormones are found in organisms in various
types. Estrone and estriol are less potent than 17β-estradiol and thus the
form responsible for many biological activities is 17β-estradiol. The
common function of estrogen is the control of sexual differentiation,
puberty, and reproduction. However, estrogens are involved in control-
ling proliferation, cell cycle, and homeostasis of various organs. Several
enzymes are involved in the process of estrogen biosynthesis [1]. Among
such enzymes is the aromatase enzyme that converts androgens to es-
trogens. The cytochrome P450 enzyme (CYP19) (11β-hydroxysteroid
dehydrogenase) is from the cytochrome P450 family [2] that was enco-
ded by the CYP19 gene [1]. Cancer is one of the causes of mortality and
morbidity in the world, especially in the third world countries. It isGhorbani).
5 December 2019; Accepted 4 M
is an open access article under tcharacterized with uncontrolled growth and multiplication [3]. In breast
cancer, the expression of CYP19 increases and thus cell proliferation by
estrogen increases [2]. Aromatase is a prime enzyme that regulates es-
trogen biosynthesis in local and systemic levels in the body [1]. Using
aromatase inhibitor is a treatment method of breast cancer in post-
menopausal women. Several synthetic compounds have been designed
for inhibiting aromatase. In addition, nowadays, natural products are
used for inhibition of aromatase in order to detect a novel approach for
treatment of breast cancer [4].
Phytochemicals are derived from a plant with a phenolic compound
being the major class of them. Phytochemicals are used to inhibit the
aromatase enzyme. The aromatic ring structure is the basic structure of
phenolic compounds with other elements such as oxygen atoms, methyl
groups and sugars being a part of its structure. Phenolic compounds arearch 2020
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Figure 1. Process of study selection based on PRISMA flowchart.
F.H. Balam et al. Heliyon 6 (2020) e03557classified into different groups such as flavonoids, phenolic alcohols,
phenolic acids, stilbenes and lignans. The largest group of phenolic
compounds with low molecular weight is flavonoids that are widely
found in fruits and plants and are divided into six groups including fla-
vanones, flavones, isoflavones, flavonols, flavanols as well as anthocya-
nins [5, 6] and proanthocyanidins [7]. Secondary metabolites like
flavonoids function as the first line of defense against oxygen radical
production, ultraviolet rays and/or invasive organisms in plant species.
Diversities of flavonoid subgroups depend on a heterocyclic C ring
structure binding to A and B phenolic rings with double bonds [6] and
also on the degree of hydroxylation and substitutes [8].
Sources of flavonoids are fruits, vegetables, nuts, and grains, as well
as various herbs and spices. Flavonoids have antibacterial, antiviral,
antioxidant, anti-allergic, anti-inflammatory and anticancer [3, 9] capa-
bilities. Chrysin (5, 7-dihydroxyflavone) is a polyphenolic flavone that
has a high concentration in honey and propolis. Chrysin as an apigenin
analog has the high remedial power of transferring the intestinal mem-
brane and also has anti-inflammatory [10] and antioxidant [11] capa-
bilities. Chrysin is reported to have the highest aromatase inhibitory
potency and stimulate cell apoptosis. Thus, it can be engaged in the
prevention of cancer or cancer treatment [8]. The aim of this review was
to prove the claim that chrysin could inhibit aromatase and increase
testosterone level.
2. Methods
We used the Preferred Reporting Items for Systematic Reviews and
Meta-Analysis (PRISMA) statement to perform and report this systematic
review [12].
2.1. Search strategy
Three databases including PubMed (www.pubmed.com), Science
Direct (www.sciencedirect.com) and Google Scholar (Scholar.goog
le.com) were researched up to 5 February, 2019. MeSH and non-MeSH
terms were used as follows: (‘chrysin’ OR ‘flavonoid’) AND (‘androgen’
OR ‘testosterone’ OR ‘estradiol’ OR ‘estrogen’) AND (‘mutagenesis’ OR
‘aromatase inhibitor’). Further, citations were known by manual mar-
keting lists of all the selected articles and reference list of relevant articles
were searched to select the eligible article. The citation was saved and
managed by the EndNote X5 reference software. The process of selecting
articles is shown in Figure 1.
2.2. Eligibility criteria
We included studies that reported the effect of chrysin on aromatase
activity enzyme, regardless of their type, date, and outcomes. The
excluded studies were narrative reviews, conference abstracts and pe-
rusals that did not report the outcomes of interest or their full texts were
not available. Studies not written in English were included only if the
abstract was translated into English.
2.3. Data extraction
The extracted data from the studies included first author's name, year
of publication, study location, material study, sample, test method, out-
comes, and main results. Study data were extracted and recorded into the
summary table.
2.4. Quality assessment of studies
Risk of bias assessment of included studies was evaluated using the
Science in Risk Assessment and Policy (SciRAP) in vitro reporting
checklist (Table 1) [13]. The risk of bias for each included study cate-
gorizing the following items: purpose, endpoint, test compound, vehicle,
ethical statement, test system, administration of test compound,2
methods, statistics, data, discussion, other. In fact, the SciRAP method
evaluates both the reporting quality and the methodological quality of
the studies. To evaluate the risk of bias, each study was assigned a label
(fulfilled, partially fulfilled, not fulfilled and not determined). The overall
quality score was judged as poor, fair and good, where score was clas-
sified as 0–5, 6–9, 10–14, respectively [14].
3. Result
Summary of extracting data from this systematic review is described
in Table 2.
Kellis et al. [15] investigated the effect of flavones on aromatase, the
cytochrome P450 enzyme, in human placental microsomes obtained
from premenopausal women after normal deliveries. The activity of
aromatase was measured by the release of tritium from (1, 2–3H) an-
drostenedione or from (1, 2–3H) testosterone. The aromatase inhibitory
power of flavones including 7, 8-benzoflavone, chrysin, apigenin,
flavone, flavanone, quercetin, and 5, 6-benzoflavone decreased, respec-
tively. When the 40 nM androstenedione was added as the substrate, 0.5
μM chrysin could inhibit 50 percent of the aromatase concentration
(IC50) and ki values of chrysin were 0.26 μM. It was indicated that 7,
8-benzoflavone (α-naphthoflavone) (IC50 0.07 nM), like chrysin, acted
competitively against androstenedione and was ten times as potent as
aminoglutethimide. Other compounds including chrysin (IC50 0.5 nM),
apigenin (IC50 1.2 nM), flavone (IC50 8 nM), flavanone (IC50 8 nM) and
quercetin (IC50 12 nM) were effective, but 5, 6-benzoflavone showed no
activity in this assay.
In another in vitro study, Campbell et al. [16] compared the effect of
synthetic and natural flavonoids (catechin, chrysin, flavone, genistein,
Biochanin A, quercetin, rutin, and daidzein and α-naphthoflavone (ANF)
and β-naphthoflavone (BNF)) in aromatase inhibiting with that of ami-
noglutethimide (AG), a pharmaceutical aromatase suppressor, in human
preadipocyte cells. This study showed that the tritiated water method
Table 1. Summary of the studies that examined the effect of chrysin on aromatase inhibitors.
First authors (year) location sample Test compound Aromatase assay outcomes Main result
Almstruup. K et al.
(2002)
Denmark MCF-7 cells phytoestrogens Modified estrogenicity assay Aromatase activity Aromatase inhibitors were at low
concentration (<1μM), but the estrogenic
response was at high concentration
(>1μM)
Altawash et al. (2017) Iran 40 week-old roosters chrysin Gross assessment with Burrows
and Quinn method, Lipid
peroxidation, Sperm fatty acid,
Testosterone assay and Fertility
and hatchability rates
Sperm total and forward motility,




Chrysin administration particularly at
higher levels alleviates post-peak
It reduced fertility in the roosters. It
increased blood testosterone.
Bajgai et al. (2011) Thailand MCF-7 cell line. Hybrid flavon-chalcones Based on the methodology
reported by Stressor et al.
Aromatase activity The IC50 values of chrysin was 0.8 μM
Campbell et al. (1993) U.S.A Subcutaneous adipose tissue from
female patients aged 18-42
Natural and synthetic flavonoids The Modified tritiated water Aromatase activity The IC50 values of chrysin was 4.6 μM
Dhawan et al. (2002) India Male Albino Rats Chrysin (1 mg/kg) for 30 days Sperm count and fertilization
(indirect)
Aromatase activity It raised sperm count (427*106) and
fertilization (80%)
Edmunds et al. (2005) U.S.A Endometrial stromal cell from 18
women aged 27–44 years
phytoestrogens Modified tritiated water Aromatase activity Chrysin didn't reduce aromatase activity
Gambelunghe et al.
(2003)
Italy 20 healthy male (25–30 years) (10
controls and 10 cases)
Tablets of propolis (1280mg) and
honey (20mg)
21 days
Urinary testosterone levels (GC/
MS analysis)
Hormonal equilibrium It didn't change urinary testosterone.
Jeong et al. (1999) Korea ? Flavonoids The tritiated water release assay Aromatase activity The IC50 values of chrysin was 1.1 μM
Kao et al. (1998) United
Kingdom
Chinese hamster ovary cells phytoestrogens The tritiated water release assay Aromatase activity The Ki values of chrysin was 2.6  0.1 μM
Kellis et al. (1994) Mexico Human placental microsomes flavones The tritiated water release assay Aromatase activity The IC50 values of chrysin for 40nM
androstrondion and 80nM testosterone was
0.5 and 0.4 μM, respectively
Lannone et al. (2018) Italy In vitro protocol (inhibition
kinetics experiments monitored by
GC-MS)
Flavonoids and isoflavones Modified tritiated water Aromatase activity It reduced estradiol concentrations, but
chrysin wwas not banned from monitoring
by WADA.
Le Bail et al. (2000) France Human placental microsomes phytoestrogens Unchanged radiolabelled A4 Aromatase activity The IC50 values of chrysin was 0.7 μM
Nega Ta and Thomas
Walle (2007)




Based on the methodology
reported by Stressor et al.
Aromatase activity The IC50 values of chrysin was 4.2 μM
Pelissero et al. (1996) France Rainbow trout ovarian cells phytoestrogens The tritiated water release assay Aromatase activity The IC50 values of chrysin was >1000 μM
and thus did not have inhibitory effect.
Saarinen at al. (2001) Finland JEG3 cells and Arom-HEK293 cells
AND immature female rats
(Sprague-Dawley)
flavonoids The tritiated water release assay
And measurement of uteri weight
Aromatase activity The IC50 values of chrysin was lower than 1
μM
And Induced Uterine growth (NS)
Sanderson et al. (2004) California H295R cells (human
adrenocortical carcinoma cells)
Synthetic and natural flavonoids The Modified tritiated water
isolated from the culture
Aromatase activity The IC50 values of chrysin was 7 μM
Sassa Deapaeng et al.
(2017)
Thailand Female Nile tilapia hepatic
microsomes
Chrysin, quercetin, quercitrin Based on the methodology
reported by Stressor et al.
Aromatase activity The IC50 values of chrysin was 0.25 μM
Van meeuwen et al.
(2007)
Netherlands MCF-7 cells and healthy mammary
fibroblast
phytochemicals The Modified tritiated water
isolated from the culture
Aromatase activity The IC50 values of chrysin was 1.5 μM
Van meeuwen et al.
(2008)
Netherlands Human placental microsomes and
human mammary fibroblast
Synthetic lactones and flavonoids The Modified tritiated water
isolated from the culture
Aromatase activity The IC50 values of chrysin in placental cells
was 1.1 μM
The Ki value.
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4
measured 50 percent of the concentration of aromatase activity, which
was 4.6 μM compared to aminoglutethimide (IC50 ¼ 0.5 μM). Moreover,
the other flavonoids did not affect the enzyme activity and Ki values of
chrysin were 2.4 μM. The activity of flavone and biochanin A was mar-
ginal (IC50 of 68 and 113 μM, respectively). The km of androstenedione in
the presence of 5 μM chrysin increased to 226 nM while its km increased
to 232 nM in presence of 10 μM aminoglutethimide.
Pelissero et al carried out a study for in vitro inhibition of aromatase
activity in ovarian obtained from the rainbow trout, Oncorhynchus
mykiss [17]. Aromatase activity was assayed by the technique of De
Mones and Monod et al. [18]. The study did not show any inhibitory
effect of isoflavone phytoestrogens (chrysin, apigenin, quercetin,
α-Naphthoflavone, flavanone, formononetin, daidzein, biochanin A,
genistein, coumestrol, and equol). The reason is that the IC50 values of
these flavonoids were over 1000 μM,which was close to 100 times higher
than those reported in prior studies on mammary cells.
Computer modeling in the study of Chen et al. [19] showed how
aromatase inhibitors like phytoestrogens (chrysin, 7, 8-dihydroxyfla-
vone, baicalein, galangin, genistein, biochanin A, naringenin, and
α-naphthoflavone) bound to the active site of aromatase mutants.
Chrysin binds to the wild-type aromatase and six mutant active site as a
competitive inhibitory enzyme regarding substrate because the A and C
rings of the compounds mimic the A and B rings of steroids in the active
site of aromatase. The IC50 values of chrysin for the P308F and D309A
mutants increased due to modifying the size of the active site pocket and
thus inhibited the binding of chrysin. They showed that chrysin was a
stronger inhibitor than 7, 8-dihydroxyflavone with IC50 values of 11 and
55 μM.
Kao et al. [20] tested the effect of four flavones (chrysin, 7, 8-dihy-
droxyflavone, baicalein, and galangin), two isoflavones (genistein and
biochanin A) and one naphthoflavone (α-naphthoflavone) on the
wild-type aromatase and six mutants being expressed in Chinese hamster
ovary cells. With computer modeling, the binding of phytoestrogens in
the active site was performed using the program BIOGRAPH. They
determined the ability of these aromatase inhibitors, according to their Ki
values. The Ki values were 2.6 0.1 μM for chrysin and 10 μM and 95 μM
for 7, 8-dihydroxyflavone and galangin, respectively. Computer
modeling showed how the binding of phytoestrogens to the active site of
aromatase was performed. Computer modeling proposed this orientation
for the binding of phytoestrogens to the active site of aromatase, in which
the A and C rings mimic the D and C rings of the steroid, respectively. For
this reason, chrysin was the best aromatase inhibitor among these
compounds.
In another study, Jeong et al. assessed the inhibitory effect of flavo-
noids (myricitrin, genkwanin, hyperoside, rhamnetin, tangeretin, rutin,
formononetin, rhoifolin, luteolin-30, 7-diglucose, neohesperidin, flavone,
and esculetin) on human placental microsomes. The result of the tritiated
water release assay showed that the IC50 value of chrysin was 1.1 μM,
which showed the higher potency of the inhibitor than hesperetin and
apigenin; however, other flavonoids were not active (<50% inhibition)
[21].
Le Beil et al. surveyed the estrogenic, antiestrogenic, anti-aromatase,
anti-3β-HSD and anti-17β-HSD activity of phytoestrogens in human
breast cancer cell lines (MCF-7 and MDA-MV231) and showed similar
results to those of Jeong et al. This study revealed that isoflavonoids with
the phenolic B ring in three positions on the pyran ring (coumestrol,
genistein, daidzein, and biochanin A) had much better 3β-HSD and anti-
17β-HSD activity than the aromatase inhibitor. Flavonoids including
flavone, 7-hydroxyflavone, 7-methoxyflavone, 7, 8-dihydroxyflavone,
chrysin, apigenin, and naringenin suppressed the aromatase enzyme
and 17β-HSD but did not inhibit the 3β-HSD enzyme. The IC50 values of
chrysin were assessed to be 0.7 μM, which was higher than the IC50
values of 7-hydroxyflavone but not higher than the rest [22].
The inhibition of the aromatase enzyme was measured in human
choriocarcinoma JEG3 cells and human embryonic kidney (HEK-293)
cells by the aromatase expression plasmid (pUbC-AROM) process. The
F.H. Balam et al. Heliyon 6 (2020) e03557effectiveness of three groups of aromatase-inhibiting flavonoids
including flavone, flavonol, and flavanone (apigenin, chrysin, kaemp-
ferol, quercetin, 7-hydroxyflavone, fisetin, kaempferide, luteolin, gal-
angin, naringenin, and pinostrobin) changed due to slight changes in
their social system. The IC50 values of chrysin and 7-hydroxyflavone were
<1 μM (0.5 μMand 0.35 μM, respectively) whereas flavone and quercetin
did not have any inhibitory effect (IC50> 100 μM). In addition, immature
female Sprague-Dawley rats were used to perform estrogenicity and
aromatase inhibition assays. In the in vivo part of the study, the rats were
divided into six groups and uterine weight gain was measured while the
control group (n ¼ 7) was injected s.c. with rape seed oil. The positive
control group (n¼ 9) took 10 mg/kg MPV-2213ad p.o. and rape seed oil.
In the other three groups, 50 mg/kg apigenin (n ¼ 4), naringenin (n ¼ 5)
and chrysin (n ¼ 5) were gavaged. Chrysin and naringenin had no sig-
nificant effect on the weight gain of the uterus and did not significantly
decreased uterine growth by androstenedione [23].
This study was conducted to assay the estrogenicity and aromatase
inhibitory effects of synthetic chemicals and phytoestrogens in MCF-7
cells, simultaneously. For the estrogenicity assay, cell proliferation
increasing or estrogen-induced endogenous gene initiation (expression of
pS2 mRNA) was investigated increasing. Potential aromatase inhibitors
of the tested compounds (4-hydroxy-4androstene-3, 17-dione, anas-
trozole, biochanin A, genistein, formononetin, naringenin, chrysin, red
clover flowers (dried powder, suspended in 10% (v/w) in ethanol),
nonylphenol, bisphenol A, dibutyl phthalate, and dieldrin) assessed
when exposed to testosterone pS2 MRNA expression level decreased
dose-dependently. In this study, it was shown that by adding 100 nM
testosterone to the culture medium, the expression level of pS2 mRNA
was reduced at low concentration (<1 μM) but estrogenicity of the
compounds increased at high concentration (>1 μM). The combination of
aromatase inhibition and estrogenicity led to U-shaped dose-response
curves. Biochanin A followed by naringenin and chrysin had the high
potency of an aromatase inhibitor, respectively [24].
Dhawan et al. [25] described the potential beneficial effects of iso-
flavones to counteract the adverse effects of aging on sexual male mice
behavior. To this end, male albino rats of Wistar strain were divided into
three groups (n ¼ 10 in all the groups). The control group received
vehicle (simple syrup and CMC) while one treatment group received 1
mg/kg chrysin suspended in the vehicle and the other treatment group
received orally 10 mg/kg benzoflavone moiety (BZF) suspended in the
vehicle for 30 days. In both the treatment groups, sexual functions such
as libido, fertilization potential, sperm count and litter size increased
when they were permitted to interact with proven proestrous female rats
of a similar breed. In addition, the treatment groups revealed an increase
in libido when they were permitted to interact with proven nonestrouse
mice. It appears that BZF had the higher aromatase inhibitor effect than
chrysin (sperm count was 428*106 for BZF and 427*106 for chrysin).
Gambelunghe et al. performed a study to examine the effect of chrysin
on urinary testosterone levels in human males aged 25–30 years. Since
propolis and honey are rich sources of chrysin (54 mg/g in propolis and 1
mg/g in honey), 20 gr honey and four tablets of propolis (1280mg) were
administered to healthy males for 21 days, which were consumed every
morning on an empty stomach. Urinary testosterone levels were analyzed
using the GC/MS method. The results revealed that urinary testosterone
levels of 10 males in the treatment group did not change in comparison
with baseline levels in control groups. They expected chrysin consump-
tion to result in aromatase inhibition and increased urinary testosterone
levels; however, the results did not show such effects [26].
Sanderson et al. [27] surveyed the effect of natural and synthetic
flavonoids on aromatase inhibition in H295R human adrenocortical
carcinoma cells. In this study, aromatase activity was assayed by the
method of Lephart and Simpson (1991). The study showed that the IC50
values of 7-Hydroxyflavone, chrysin, and apigenin were 4, 7 and 20 μM,
respectively. In addition, the study for the first time evaluated the aro-
matase activity of rotenone as a flavone (IC50 of 0.3 μM) after 24 h of
exposure.5
In another study, the effect of dietary phytoestrogens was assessed on
CYP19 activity in human endometrial stromal cells by Edmund et al. In
this study, they used a radiometric technique that measures the incor-
poration of tritium from (1β-3H) androstenedione into 3H-labeled water
for evaluating the aromatase inhibitory effect of phytoestrogens. The
results showed that naringenin (Ki¼ 0.3 μM) and chrysin (Ki¼ 1 μM) had
higher aromatase inhibition potency than genistein and daidzein (Ki> 50
μM). Genistein resulted in significantly increased aromatase activity (P<
0.05) whereas naringenin and chrysin inhibited aromatase activity in the
recombinant human aromatase assay [28].
In the study of Nga Ta and Thomas Walle, it was revealed that
methylated flavones such as 5,7-dimethoxyflavone, 7-methoxyflavone
and 7,4-dimethoxyflavone were more resistant to metabolism than
unmethylated analogs and thus they could inhibit the aromatase enzyme
more efficiently. Therefore, they were investigated using recombinant
CYP19 supersomes as the source of enzymes and dibenzylfluorescein as
the substrate in a 96-well format. Although 5,7-dimethoxyflavone was
the methylated form of chrysin, its effect was lower than chrysin [29].
Van meenuwen et al. examined the estrogenicity and aromatase
inhibitory effect of phytochemicals (biochanin A, genistein, naringenin,
apigenin, and chrysin) in two separate cell types, i.e. human breast
adenocarcinoma MCF-7 cells and primary fibroblasts from healthy
mammary tissues. An aromatase assay was performed using the method
of Lephan and Simpson. Initially, investigating the effect of dexametha-
sone (DEX) as an aromatase inducer in the fibroblasts showed that in-
cubation with 30 nM DEX increased after five weeks compared to a
seven-week culturing period. However, no significant effect was
observed in MCF-7 cells. Phytochemicals in the MCF-7 cells stimulated
cell proliferation where the EC50 value of chrysin was 4 μM, which was
lower than that of the other phytochemicals. Thus, the proliferation
potency of chrysin had the minimum efficacy whereas the proliferation
potency of biochanin A, genistein, and naringenin had the maximum
efficacy. Although the proliferation potency of chrysin had the least
aromatase inhibitory effect, it was more potent than the other phyto-
chemicals. At the concentration of >1 μM for chrysin and naringenin and
>10 μM for apigenin, the aromatase enzyme was significantly inhibited,
if the concentrations of 30 μM and 100 μM for chrysin and 100 μM for
apigenin were the cytotoxicity effect when measured with LDH assay
after 24 h. The IC50 value of chrysin was 1.5 μM with more potency for
aromatase inhibition whereas quercitin with IC50 ¼ 30 μM was the least
potent for aromatase inhibition. Moreover, assessing the effect of phy-
tochemicals in the co-culture of the both cell types showed that pS2
expression as a marker for measuring ER instead of cell proliferation of
the MCF-7 cells increased in response to androstenedione and testos-
terone. Biochanin A, naringenin and chrysin up-regulated pS2 expression
without testosterone at the same concentration is currently similar to that
required for cell proliferation of the MCF-7 cells only. In the presence of
20 nM testosterone, chrysin did not inhibit the aromatase enzyme at an
estrogenic concentration [30].
In a comparative study performed by VanMeeuwen et al. in 2008, the
aromatase inhibitory effect of fadrozole (FAD), 8-prenylnaringenin and a
synthetic lactone (TM-7) was investigated on both human placental mi-
crosomes and human breast fibroblasts. Apigenin (APG), chrysin, nar-
ingenin and two synthetic lactones (TM-8 and TM-9) were also examined
in human placental microsomes from a healthy woman only. After in-
cubation with dexamethasone, the mean aromatase activity was 2346 
307 pmol/h/mg protein in the microsomes while it was 4.3  1 pmol/h/
mg protein in human breast cancer fibroblasts. In placental microsomes 1
μM, 4-OH-andrestondion reduced aromatase activity by 5%. However, 4-
OH-andrestondion was significantly higher than FAD at 0.1 μM. The
degree of TM-7 (187.0  18.7), 8-PN (159.2  43.5) and APG (170.6 
16.4) inhibited the aromatase enzyme similar to 4-OH A, but at high
concentration. However, chrysin inhibited aromatase activity with the
mean of 199.5  29.0, which showed higher potency in aromatase in-
hibition compared to naringenin, apigenin, and TM-7. The IC50 values of
F.H. Balam et al. Heliyon 6 (2020) e03557the investigated compounds were in the range of 0.2–13 μM, while FAD
was about 4 nM [31].
Bajgai et al. examined the hybrid flavan-chalcones, desmosflavans A
and B with cardamonin, pinocembrin and chrysin separated from leaves
of Desmos cochinchinensis. The investigated compounds were also
evaluated for invariant types of cell lines in order to assess cytotoxicity
properties, lipoxygenase inhibition, and inhibition of superoxide anion
radical formation by the xanthine/xanthine oxidase (XXO assay) and
aromatase activity assay according to the method reported by Stresser
et al. None of the assessed compounds scavenged superoxide anion
radicals. However, cytotoxic activity toward HuCCA-1, HepG2, A549,
and MOLT-3 cancer cell lines with the IC50 values of chrysin for the XXO
assay was 79.8 μM. The IC50 value of chrysin aromatase inhibition was
0.8 μM; while cardamonin was inactive, desmosflavans A and B and
pinocembrin were the aromatase inhibitors with IC50 values of 1.8, 3.3
and 0.9 μM, respectively [32].
The report of Altawashs et al. showed the effect of chrysin on the
sperm quality, fertility, fatty acid composition, hatchability rates and
blood testosterone levels of 28 sexually mature Ross 308 roosters for 12
weeks. The roosters were divided into four groups and consumed
capsulated chrysin in doses of 0 (Ch0), 25 (Ch25), 50 (Ch50) or 75
(Ch75) mg/bird/day. Body sampling, semen, and blood sampling were
carried out every week. All the three artificial inoculations were per-
formed in the last two weeks of the experiment. In addition to body
weight, total and forward sperm mortality were reduced by 7% in both
the Ch50 and Ch75 groups. The interaction of time and treatment for
sperm total and forward mortality, plasma membrane functionality, and
integrity was significant. In both the Ch50 and Ch75 groups, plasma
membrane functionality (71.41 and 70.2, respectively) and integrity
(83.42 and 84.42, respectively) increased. Moreover, the seminal MDA
content decreased significantly, but was not significant between the
groups. However, blood testosterone levels increased by 5% only in the
Ch75 group. When the semen sample was calculated in the 12th week, the
fatty acid profile of the sperm plasma membrane was assessed. This
assessment showed that the total saturated fatty acid reduced from 45.49
in the Ch0 group to 41.99, 40.29 and 39.89 in the Ch25, Ch50, and Ch75
groups, respectively. The fertility and hatchability rates increased by 7
and 6%, respectively, and became 87.4 and 86 for the Ch50 and Ch75
groups as compared to 81.2 in the control group. Finally, in the 12th
week, all the roosters were slaughtered and their testicles were removed,
attentively. The testis index was not significantly different among the
treated groups [33].
Iannone et al. probed the effects of two main synthetic isoflavones,
namely ipriflavone and methoxyisoflavone, on the catalytic activity of
CYP19 and compared them with natural flavonoids (chrysin, quercetin,
and daidzein) and synthetic aromatase inhibitors already considered in
the WADA prohibited list (formestane, anastrozole, and amino-
glutethimide, included in the section S4 of hormones and metabolic
modulators). Due to the incubation of various concentrations of synthetic
aromatase inhibitors (0.4, 0.8, and 1.2 μM) with 1 μM of the substrate
(testosterone), a decrease was indicated in the effect on CYP19. The in-
cubation of natural flavonoids according to their IC25, IC50, and IC75
(formestane, anastrozole, and aminoglutethimide 0.4, 0.8, and 1.2 μM,
respectively; daidzein 1, 5, and 10 μM; chrysin 0.35, 0.7, and 1 μM; and
quercetin 25, 50, and 100 μM) led to decreased aromatase activity,
competitively. After the incubation of methoxyisoflavone and ipriflavone
at different concentrations (5, 10, and 50 μM), they decreased the con-
version of testosterone to estradiol. The Ki values of ipriflavone and
methoxyisoflavone were 0.19 μM and 0.36 μM, respectively. Thus, two
synthetic isoflavones were competitive aromatase inhibitors [5].
4. Discussion
The aim of this review was to prove this claim that chrysin as a
flavonoid can inhibit the aromatase enzyme. Most of the studies showed
the inhibition effect of chrysin on aromatase activity. Aromatase, i.e.6
cytochrome P450, catalyzed the biosynthesis of estrogen from testos-
terone excessive estrogen and had a major effect on cell proliferation and
cell cycle. Abnormal aromatase expression plays an important role in
increasing breast cancer cells and endometriosis [1, 28]. In addition, in
men, estrogen could contract seminiferous tubules and might have
mitogenic effects on Sertoli and Leydig cells [26]. In the reviewed
studies, in addition to chrysin, other phytochemicals such as iso-
flavonoids, flavonones, as another subgroup of flavone, and even syn-
thetic flavonoids were assessed for their aromatase inhibitory potency.
Chrysin is a dihydroxyflavone, in which two groups of hydroxyl are
located at the positions 5 and 7 of the A ring [9]. According to the
literature, flavones had higher aromatase inhibition potency than flava-
nones, isoflavones and isoflavones, respectively. Although the test of
aromatase inhibitory features of flavonoids has not been performed on
human populations, a mechanism is indicated, in which flavonoids can
be applied to prevent or treat cancers [9, 34]. Probably the A and C rings
of the activity site of aromatase mimic the D and C ring of the substrate
[20]. Thus, flavonesmight compete with steroids to bind to the active site
of aromatase. Chrysin is the best aromatase inhibitor among flavones
since the hydroxyl group at the position 7 is the essential factor for in-
hibition [23, 35]. The 4-keto group of the C ring led to enhanced
inhibitory potency of flavonoids [36, 37]. Because of being the hydroxyl
group at the 5 position in the A ring (chrysin), its inhibitory potency was
lower than 7-hydroxyflavone due to the formation of a hydrogen bond
with the 4-keto group [20, 35, 36, 37]. The 4-keto group of chrysin
pointed toward the heme prosthetic group, but C5 hydroxyl reduced the
interaction of chrysin with the heme [20, 38, 39]. Likewise, a model
clarified why some polyphenols such as epicatechin and epigallocatechin
did not have an aromatase inhibitory feature, due to lack of the keto
group [20]. Reduction of the carbonyl group to 4-hydroxyl caused the
decrease of inhibitory potency like flavone-4-ol (IC50 ¼ 120 μM) [35].
Apigenin and naringenin can inhibit aromatase at the 1 μM concentration
and thus their aromatase inhibition potency is lower than chrysin due to
being the hydroxyl group at the three positions of flavone [40]. More-
over, even the inhibitory potency of the inhibition of naringenin was less
than that of apigenin because of changing the C2 and C3 double bond to a
single bond [40]. The single bond between C2 and C3 in naringenin, by
reducing the electronegativity of the 4-keto group, prohibited the inter-
play of this group with the prosthetic group [20, 23]. Quercitin, quer-
cetin, and chrysin aromatase inhibitory potency increased, respectively
[15, 41]. The core structure of the three compounds was the same but
quercetin had two hydroxyl groups at the C30 and C40 positions [42], and
adding the glycoside formed from deoxyrhamnose substitution at C3 to
quercetin yielded quercitrin [38]. Therefore, the structure of the com-
pounds was related to the activity of aromatase with regard to the hy-
drophobic of the active site of aromatase, the substitution of the OH
group or sugar led to decreased hydrophobicity of chrysin and lowered
its potential anti-aromatase activity [41]. The 40, 5, 7-trihydroxy-8-pre-
nylnaringenin (8-PN) is a prenylflavonoid where the prenyl group is
located on C8 and its potential anti-aromatase is higher than that of
chrysin [31, 43]. The prenyl group, in contrast to the hydroxyl group, at
the C8 position in 7, 8-dihydroxyflavone [20] led to increased potency of
anti-aromatase activity. The IC50 values of chrysin in reviewing studies
were between the range of 0.5 and 5 μM. The condition of the experiment
is among the essential parameters that can create different results. Con-
ditions used for incubation, amounts of proteins incubated, pre-
incubation time and conditions, incubation time and the sample used are
conditional parameters that may have an effect on the degree of inhibi-
tion and IC50 values [17, 21, 27, 28]. For example, naringenin and
chrysin were ineffective on aromatase inhibition in endometrial stromal
cells while genistein induced increased aromatase activity. However,
these compounds are beneficial in breast cancer.
The low oral bioavailability was because of the release of the hy-
drolyzing enzyme and interaction with another substrate in the gastro-
intestinal tract [26]. Humans' diet contains several flavonoids at different
concentrations and thus it is difficult to measure the net effect of one
F.H. Balam et al. Heliyon 6 (2020) e03557component such as chrysin on aromatase activity. The mixture of flavo-
noids in foods may have an inhibitory or inductive effect on the aro-
matase enzyme or another enzyme that have a role in antioxidation,
anti-inflammatory, etc. Therefore, it is difficult to determine the con-
centration of flavonoids in human blood plasma. Since various factors
affect flavonoids (e.g., chrysin) performance, consumption of single
flavonoid supplementation can sufficiently increase the tissue concen-
tration of single flavonoid to inhibit the aromatase enzyme. The drasti-
cally decreased biosynthesis of the induced estrogens induces disrupt in
the menstrual cycle in females [44], impaired spermatogenesis [45] and
disrupted bone homeostasis in both genders [46].
In brief, the 4-keto group in the C ring appeared to be necessary for
inhibiting the aromatase enzyme. In that event, compounds such as s
catechins or anthocyanidins, due to the lack of the 4-keto group, cannot
inhibit aromatase [47]. The presence of the 7-hydroxy or 7, 8-benzo
group on the A ring enhanced aromatase inhibition. Big substitutions
on the 5- or 6-position of the A ring as well as substitutions on the 3-po-
sition of the C ring can reduce the electronegativity of the 4-keto group
and decrease aromatase activity, ultimately. In addition, the existence of
electron donating groups on the B ring improves the potency of aroma-
tase inhibition, however, the above constructions are not essential for
anti-aromatase activity.
5. Conclusion
In conclusion, the results of this study suggest that dietary com-
pounds, such as chrysin, which are found in foods such as honey and
propolis can reduce estrogen production. Chrysin is an almost strong
aromatase inhibitor in a subgroup of phytochemicals, which can inhibit
the proliferation of cancer cells as well. Since much of the research is
performed in vitro, in vivo studies are required to evaluate the aromatase
inhibition potency of chrysin.
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